Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serah Choi

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
Radiation Research|July 28, 2009
Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiationJulie P Goff, Donna S Shields, Mineaki Seki, et al.
Radiation Research|August 24, 2010
Intraesophageal manganese superoxide dismutase-plasmid liposomes ameliorates novel total-body and thoracic radiation sensitivity of NOS1-/- miceMalolan S Rajagopalan, Brandon Stone, Jean-Claude Rwigema, et al.
International Journal of Particle Therapy|April 8, 2021
Proton Beam Therapy in the Treatment of Periorbital MalignanciesNicholas J Damico, Anna K Wu, Michael Z Kharouta, et al.
Science (New York, N.Y.)|May 16, 2015
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancerRobert J A Bell, H Tomas Rube, Alex Kreig, et al.
Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Cancers|June 19, 2024
Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based ApproachDu Wang, Huaizhi Geng, Vinai Gondi, et al.
The Journal of Clinical Investigation|March 1, 2023
Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effectsSaket Jain, Jonathan W Rick, Rushikesh S Joshi, et al.
Neuro-Oncology|November 16, 2024
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825Joshua D Strauss, Mark R Gilbert, Minesh Mehta, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2023
Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized TrialIn Ah Kim, Kathryn A Winter, Paul W Sperduto, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
Radiation Research|July 28, 2009
Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiationJulie P Goff, Donna S Shields, Mineaki Seki, et al.
Radiation Research|August 24, 2010
Intraesophageal manganese superoxide dismutase-plasmid liposomes ameliorates novel total-body and thoracic radiation sensitivity of NOS1-/- miceMalolan S Rajagopalan, Brandon Stone, Jean-Claude Rwigema, et al.
International Journal of Particle Therapy|April 8, 2021
Proton Beam Therapy in the Treatment of Periorbital MalignanciesNicholas J Damico, Anna K Wu, Michael Z Kharouta, et al.
Science (New York, N.Y.)|May 16, 2015
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancerRobert J A Bell, H Tomas Rube, Alex Kreig, et al.
Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Cancers|June 19, 2024
Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based ApproachDu Wang, Huaizhi Geng, Vinai Gondi, et al.
The Journal of Clinical Investigation|March 1, 2023
Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effectsSaket Jain, Jonathan W Rick, Rushikesh S Joshi, et al.
Neuro-Oncology|November 16, 2024
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825Joshua D Strauss, Mark R Gilbert, Minesh Mehta, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2023
Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized TrialIn Ah Kim, Kathryn A Winter, Paul W Sperduto, et al.
Pageof 6